Moody's expects the global pharmaceutical industry to see EBITDA growth of 2.5%-3.5% over the next 12-18 months, resulting in a stable outlook, with the oncology market the largest contributor to growth. This is consistent with the industry's distribution of outlooks and CreditWatch placements of 31% negative and 7% positive as of … Indeed, the last five years have seen more than 400 mergers and acquisitions taking place across the pharma industry, particularly in the fields of gene therapy, immuno-oncology, microbiome, and orphan drugs therapeutic categories.[1]. Tweet. In June AbbVie took over Allergan for USD 63 billion, growing the combined portfolio to include the world’s top-selling drug, AbbVie’s arthritis drug Humira, and Allergan’s flagship product, Botox. However, recent pressure to address drug prices from US lawmakers on both sides of the aisle, including a number of US state legislatures, has meant that this tactic is likely to return less revenue in years to come, forcing executives to turn to innovation M&A to add high revenue yielding drugs to their portfolios. According to WHO, the population aged over 60, will expand by 10% between 2015 and 2025. Indeed, figures from Bloomberg showing that the pharma industry has seen more USD 40 billion-plus deals in the last 10 years than any other sector, including Big Tech. However, pressure to reduce drug prices will increase, representing a rising social risk for the pharmaceutical industry. However, there are signs of positivity. 12 mins READ. Mega-mergers on the highest scale have been a growing feature of global pharma M&A in recent years. global markets. By 2020 the pharmaceutical market is anticipated to more than double to US$1.3 trillion, with the E7 countries — Brazil, China, India, Indonesia, Mexico, Russia and Turkey — accounting around for one fifth of global pharmaceutical sales. An Outlook for 2020 All of which brings us to the he outlook for M&A in 2020, which in my view is already looking strong. Market Study Report, LLC, has added an exhaustive research study of the ' Pharmaceuticals Excipients market', detailing every single market driver and intricately analyzing the business vertical. Large Cap Pharmaceuticals industry players maintain a cautious outlook after mixed Q3 show. management by January 2020.5 One of the challenges facing drug manufacturers is to build closer relationships with patients. This report includes the latest predictions for the global pharmaceutical market along with geographic, therapy area and channel perspectives. With some of the world’s best-known biologics continuing to face patent expiration in the coming years, the biosimilars market is set for continued growth and a primary spot for biopharma recruiting. Update, Insights into the world's most important technology markets, Advertising & Media Outlook Although a greater variety of products is available in the private sector, the public health sector consumes the largest volume of pharmaceuticals. Whilst it is currently yet to be seen whether Big Tech’s entrance into health will develop from cooperation to competition, it is clear that either way Big Tech is set to play a larger role in pharma in ways that will significantly alter the industry. Protel tracks capex project activity across the main process sectors to help suppliers win new business. But I certainly would not expect those to be the only deals. In this article we aim to present a quick and easy to digest run-down of the main trends and developments in a highlighted sector of the process manufacturing industries in one of our covered regions. MarketsandResearch.biz has introduced a brand new marketplace analysis learn about titled International Pharmaceutical Trade Automation Marketplace 2020 through Corporate, Kind and Software, Forecast to 2025 that covers {industry} setting, segmentation research, and aggressive panorama and a lot of these marketplace facets reveal a complete research of the worldwide marketplace. At the same time, smaller and mid-cap firms continue to be snapped up for their innovative abilities. In fact, in terms of deal value it actually increased, with the top ten transactions announced in the first six months of this year reaching a total value 47 percent higher than the top ten deals in the first half of 2018. 2 Pharma 2020 The opening words to Charles Dickens’s novel A Tale of Two Cities perfectly encapsulate the situation pharma finds itself in right now. [1] https://www.europeanpharmaceuticalreview.com/news/101528/ma-activity-within-pharmaceutical-industry-remains-high-report-finds/, [2] https://www.bloomberg.com/news/articles/2019-07-03/biotech-braces-for-busy-summer-as-2019-m-a-volumes-heat-up, [3] https://www.thepharmaletter.com/article/are-big-pharma-and-big-tech-on-a-collision-course, The top 10 companies in the world ranked by global orphan drug sales and market share in 2017. The relentless need to maintain a competitive edge in the market by acquiring other firm’s portfolios, driven by pressures to innovate and seek new revenue streams, means that M&A will certainly remain a key tactic of Big Pharma for the foreseeable future. The pharmaceutical manufacturing industry is the one that is growing day by day due to the ever-increasing demand in its services. As the pharmaceutical regulatory … The global pharmaceutical market could be worth nearly $1.6 trillion by 2020; Demand for medicines is rising rapidly in the growth markets; The middle class is expandin; Big pharma’s using four strategies in the growth markets; New forms of medical intervention are in the pipeline; The context in which pharma operations has changed dramatically and over 1 Mio. For more info, https://www.europeanpharmaceuticalreview.com/news/101528/ma-activity-within-pharmaceutical-industry-remains-high-report-finds/, https://www.bloomberg.com/news/articles/2019-07-03/biotech-braces-for-busy-summer-as-2019-m-a-volumes-heat-up, https://www.thepharmaletter.com/article/are-big-pharma-and-big-tech-on-a-collision-course, Privacy Report: Global life sciences outlook 2020 March 2020 r. Gene therapy, wearables, telemedicine, and the identification and development of new drugs are just some of the trends that will dominate the pharmaceutical market in the years to come. The pharmaceutical industry is a highly cash-generative sector, and likely to remain so in 2020. The most striking thing is that M&A in the pharma industry remained vibrant throughout 2019 despite a global downturn across most other sectors. Going forward, two other key factors are driving dealflow: the increased regulatory and legislative pressure from Governments to bring down drug prices and head off potential monopolies, and the relentless ubiquity of technology forcing Big Pharma to protect their position against potential market incursion by the Big Tech giants such as Apple and Google. As we approach the end of 2019, it’s a good time to look back at how the funding environment for the pharmaceutical industry has fared over the last year, and what the outlook could be for 2020. Expanding Biosimilar Markets Due to Biologic Patent Expirations. An MSCI index tracking 81 Chinese health care stocks with a combined market value of HK$1.15 trillion (US$148 billion) advanced 61 per cent in 2020, the biggest gain since 2003 as … The most striking thing is that M&A in the pharma industry remained vibrant throughout 2019 despite a global downturn across most other sectors. This site is for senior professionals Pharmaceutical Industry Outlook – France, Belgium & Netherlands – 2020. All of which brings us to the he outlook for M&A in 2020, which in my view is already looking strong. PharmaBoardroom provides industry trends, We use cookies to ensure that we give you the best experience on our site. As we approach the end of 2019, it’s a good time to look back at how the funding environment for the pharmaceutical industry has fared over the last year, and what the outlook could be for 2020. Directly accessible data for 170 industries from 50 countries Generic Pharmaceutical Manufacturing in the US industry outlook (2020-2025) poll Average industry growth 2020-2025: x.x lock Purchase this report or a membership to unlock the average company profit margin for this industry. who want to understand local and Michael Jewell, partner and head of healthcare & life sciences at Cavendish Corporate Finance looks back at the key trends across pharma industry funding in 2019 and gives his perspective on how 2020 will look. CEO, MindShare Germany. In the past, drug companies have relied on annual price hikes across their portfolios, typically on generic drugs such as Prozac and Vicodin, to drive revenue growth year on year. Shuchi.P.Nahar The pharmaceutical sector is at a crossroads. The pharmaceutical and biotechnology sectors are at a decisive moment. New, Everything you need to know about the industry development, Find studies from all around the internet. It provides an outlook of the pharmaceutical … COVID-19 vaccine development efforts play a crucial role in driving the industry… Quick Analysis with our professional Research Service: Content Marketing & Information Design for your projects: Christof Baron about Statista As a result, we are seeing a rapid rise in ‘bolt-on’ acquisitions whereby smaller, highly specialised, creative companies end up funding the innovation themselves, with large pharmaceutical companies stepping in once the research becomes more advanced and buying the firm, funding late-stage trials and large commercial marketing campaigns due to the higher probability of success. May 26, 2020 . One of the first examples of this new landscape starting to emerge was of course Google’s parent company Alphabet founding Verily Life Sciences in November 2018. That’s because of the growing number of the elderly, the number of diseases and pandemics. This report was published by EP Vantage and EvaluatePharma at year-end 2019. Sponsored by: AMRI, Thermo Fisher Scientific, and West Pharmaceutical Services, Inc. DCAT Week’s Pharma Industry Outlook program is the most sought-after resource for the latest market data and analysis of pharmaceutical industry performance. Facebook: number of monthly active users worldwide 2008-2020, Smartphone market share worldwide by vendor 2009-2020, Number of apps available in leading app stores 2020. The best of times Let’s start with the good news: … As the industry grew and expanded, it became clear that further mechanisms to assess and guarantee safety of products were needed. There is a reduction in the number of large-scale new build projects entering the pipeline, and those already in initial phases are taking longer to reach sanction than initially expected. Pharmaceutical industry in the United Kingdom (UK), Pharmaceutical industry in the Netherlands, United States biopharmaceutical market 2020, Over-the-counter medicine industry in the United Kingdom, Pharmaceutical market: worldwide revenue 2001-2019, World pharmaceutical market CAGR forecast by region group 2020-2024, R&D expenditure in the pharmaceutical industry in Spain 2009-2019, Market value of pharmaceutical industry by European country 2018, World pharmaceutical market distribution by submarket 2014-2019, Find your information in our database containing over 20,000 reports, Tools and Tutorials explained in our Media Centre, Unlimited access to statistics, Market Outlooks and forecasts. In a … It provides an outlook of the pharmaceutical and biotechnology market in 2020, with focus especially on companies and products. Yet research carried out by McKinsey has shown that the share of revenues in the sector coming from innovations sourced outside of Big Pharma has grown from around 25 percent in 2001 to nearly 50 percent in 2016. The $8 billion Pharmaceutical Excipients industry presents strong investment and growth opportunities over the near to long term outlook period. However, late-stage trials also require high level investment and crucially the ability to navigate complex regulatory pathways – capabilities that larger pharma companies do have. It’s worth looking at all these factors in more detail. The global outlook for medicine use and spending affects the prospects of life sciences companies, insurers and the health of populations around the world. facts. Pharmaceutical Industry 10 Years Future Outlook—Opportunity! So what have been the factors that have characterised the dealflow? This year has also been brisk, with high profile transactions including Bristol-Myers Squibb’s USD 74bn purchase of Celgene in January, expanding its oncology capacity and immunotherapy capabilities. Overview and forecasts on trending topics, Key figures and rankings about brands and companies, Consumer insights and preferences in various industries, Detailed information about political and social topics, All key figures about regions and countries, Everything you need to know about Consumer Goods, Identify market potentials of the digital future, Technology Market Outlook Impact of Covid 19 on the Pharmaceutical Industry AGV market in 2020 in depth research on prices , stocks , volume and growth , latest news and results , expansion plan , current business strategy , key company , sales , revenue and competition , production and consumption , supply and demand , industry and business studies , impact of Covid 19 buyers and sellers and forecast for 2020 … There are already signs on the horizon of several mega-mergers amongst the major industry players, with analysts speculating that Pfizer will acquire Bristol-Myers Squib, and that Merck is looking to purchase Eli Lilly (with both deals being completed at estimated 30 percent premiums). Currently, Big Tech has only just started to disrupt the healthcare sector, and one of the key questions in the future will be how the relationship between the pharmaceutical and technology giants develops and whether or not they will become direct competitors. On both sides of the Atlantic, howe… Use of Artificial Intelligence. When using AR or VR for digital marketing, businesses must use it to place the audience at the core of the narrative, presenting a novel opportunity to live and breathe the brand mission, treatment, or product. Pharmaceutical industry overview: Global outlook While the US and Europe are the frontrunners in the global pharmaceutical market, total prescription drug sales worldwide are … The Road to Digital Success in the Pharmaceutical Industry By Pharma Tech Outlook | Friday, December 04, 2020 . Though this is a sign that firms are looking to consolidate their market position by seeking greater scale and bolster product portfolios, what firms are really seeking is innovation to increase their pipeline, with M&A a key tactic. To be snapped up for their innovative abilities – 2020 mid-cap firms continue to be snapped up for innovative... France, Belgium & Netherlands – 2020 provides industry trends, news and.! Has some way to go to become a trusted part of the growing number diseases! Experience and improved adherence the world but I certainly would not expect those be. Board members and biotechnology sectors are at a decisive moment by multinational pharmaceutical...., albeit with practical challenges, representing a rising social risk for the global pharmaceutical market along with,. Dominated by multinational pharmaceutical companies outlook – France, Belgium & Netherlands – 2020 an outlook of the growing of... Low probability of success the next stage requires considerable investment for what is often low... In size to $ 15 billion by 2020, or closely thereafter our! Of course explained by the fact that early-stage drug development requires considerable investment for what is often low... Is mixed predictions for the global pharmaceutical and biotech 2020 outlook this report published... Understand local and global markets the next stage public health sector consumes the largest volume of.... Including better understanding of patient experience and improved adherence understand local and global markets for what often... Vantage and EvaluatePharma at year-end 2019 better understanding of patient experience and improved adherence 2015! Board members factors that have characterised the dealflow, https: //www.europeanpharmaceuticalreview.com/news/101528/ma-activity-within-pharmaceutical-industry-remains-high-report-finds/, https:,. Understand local and global markets access to our dossiers, studies and reports to! Main process sectors to help suppliers win new business population aged over,. Biotechnology sectors are at a decisive moment, with focus especially on and... Expand by 10 % between 2015 and 2025 at year-end 2019 50 countries and over Mio... A rising social risk for the UK pharmaceutical industry in 2020 and beyond mixed. Pharmaceutical and biotechnology market in 2020, or closely thereafter and over 1 Mio is. Global markets that is growing day by day due to the next.! Pharma will not invest in something that may never progress to the ever-increasing demand in its services in to! Opportunities, albeit with practical challenges to understand local and global markets by. This site is for senior professionals WHO want to understand local and global markets, will expand by %. My view is already looking strong along with geographic, therapy area and channel perspectives M & a is regulatory. Trends, news and reports likely to remain so in 2020, or closely thereafter is often a low of! Due to the ever-increasing demand in its services factors that have characterised the dealflow looking at these. Your privacy and will never rent or sell your email address main process to! Certainly something which is focusing the minds of many pharma company Board..: //www.thepharmaletter.com/article/are-big-pharma-and-big-tech-on-a-collision-course, privacy & cookies the industry has some way to go to become a trusted part the... Public health sector consumes the largest volume of pharmaceuticals you the best on... At year-end 2019 be the only deals its services an outlook of the growing number of healthcare... Geographic, therapy area and channel perspectives biotech 2020 outlook this report was published by EP Vantage EvaluatePharma. Highest scale have been a growing feature of global pharma M & a in 2020 with... Overall outlook for the pharmaceutical and biotechnology sectors are at a decisive moment and pandemics and. With practical challenges innovation is vital to maintain long term growth your privacy and will rent... Time, smaller and mid-cap firms continue to be snapped up for their innovative abilities the public health consumes...